Molnupiravir, also known by its brand name MK-4488, represents a notable advancement in the battle against COVID-19. This taken by mouth antiviral drug works by introducing errors into the SARS-CoV-2's genetic sequence, effectively preventing its copying and progression within the body. While first data suggested a substantial reduction in hospital